06.02.25 |
A.P. Moeller - Maersk A-S Neutral |
UBS AG |
|
06.02.25 |
AstraZeneca Overweight |
JP Morgan Chase & Co. |
|
06.02.25 |
Novo Nordisk Buy |
UBS AG |
|
06.02.25 |
Novo Nordisk Overweight |
JP Morgan Chase & Co. |
|
05.02.25 |
Novo Nordisk Market-Perform |
Bernstein Research |
|
05.02.25 |
Novo Nordisk Buy |
UBS AG |
|
05.02.25 |
Novo Nordisk Buy |
Goldman Sachs Group Inc. |
|
05.02.25 |
Novo Nordisk Overweight |
JP Morgan Chase & Co. |
|
05.02.25 |
Novo Nordisk Underperform |
Jefferies & Company Inc. |
|
03.02.25 |
Novo Nordisk Buy |
UBS AG |
|
03.02.25 |
Volvo AB Overweight |
JP Morgan Chase & Co. |
|
03.02.25 |
AstraZeneca Overweight |
JP Morgan Chase & Co. |
|
03.02.25 |
Hennes & Mauritz AB Underperform |
Bernstein Research |
|
03.02.25 |
Hennes & Mauritz AB Sector Perform |
RBC Capital Markets |
|
03.02.25 |
Ericsson Sell |
Goldman Sachs Group Inc. |
|
03.02.25 |
Volvo AB Buy |
Jefferies & Company Inc. |
|
03.02.25 |
Nokia Hold |
Jefferies & Company Inc. |
|
31.01.25 |
ABB Sell |
Deutsche Bank AG |
|
31.01.25 |
Nokia Neutral |
UBS AG |
|
31.01.25 |
Nokia Buy |
Deutsche Bank AG |
|
31.01.25 |
Nokia Sell |
Goldman Sachs Group Inc. |
|
31.01.25 |
Hennes & Mauritz AB Sell |
Goldman Sachs Group Inc. |
|
31.01.25 |
ABB Neutral |
UBS AG |
|
30.01.25 |
Hennes & Mauritz AB Underweight |
JP Morgan Chase & Co. |
|
30.01.25 |
Volvo AB Buy |
Deutsche Bank AG |
|
30.01.25 |
Ericsson Neutral |
JP Morgan Chase & Co. |
|
30.01.25 |
Nokia Market-Perform |
Bernstein Research |
|
30.01.25 |
ABB Underperform |
Bernstein Research |
|
30.01.25 |
Volvo AB Neutral |
UBS AG |
|
30.01.25 |
AstraZeneca Neutral |
UBS AG |
|
30.01.25 |
Nokia Overweight |
JP Morgan Chase & Co. |
|
30.01.25 |
ABB Neutral |
UBS AG |
|
30.01.25 |
Nokia Neutral |
UBS AG |
|
30.01.25 |
Hennes & Mauritz AB Buy |
UBS AG |
|
30.01.25 |
Hennes & Mauritz AB Sell |
Goldman Sachs Group Inc. |
|
30.01.25 |
Nokia Sell |
Goldman Sachs Group Inc. |
|
30.01.25 |
Hennes & Mauritz AB Sector Perform |
RBC Capital Markets |
|
30.01.25 |
ABB Neutral |
Goldman Sachs Group Inc. |
|
30.01.25 |
ABB Sector Perform |
RBC Capital Markets |
|
29.01.25 |
Novo Nordisk Buy |
UBS AG |
|